Searchable abstracts of presentations at key conferences in endocrinology

ea0062p45 | Poster Presentations | EU2019

Delivery of a diagnosis

Mathew SV , Mumby C

Case history: A 32 female was referred to a tertiary maternity unit due to hypercalcaemia and a diagnosis of primary hyperparathyroidism (PHPT). She had learning difficulties, 2 previous C-sections and was a smoker. She presented 5 years earlier to her local hospital with abdominal and leg pains, nausea, constipation and fatigue. She had undergone 2 parathyroidectomies but remained hypercalcaemic and had been managed medically with Cinacalcet when she conceived an unplanned pr...

ea0011p201 | Clinical practise and governance | ECE2006

Knowledge of testosterone replacement therapy is significantly correlated with patient satisfaction suggesting greater need for education

Llahana SV , Conway GS

The purpose of this study was to explore the use of testosterone treatment and patients’ knowledge in male hypogonadism. A questionnaire was sent to all 213 patients on testosterone replacement therapy recorded in our clinic database, with a response rate of 35.7% (n=76). Respondents’ age ranged from 19 to 87 years (mean=44.5; S.D.=16.2). Causes of hypogonadism for this group are presented in Table 1.<table boarder="1" cellpadding="3" cellsp...

ea0070aep383 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Association of AdipoQ gene & its expression in adipose tissue with post prandial hypertriglyceridemia and glucose intolerance

SV Madhu , Mishra Brijesh , Banerjee Basudev , Mohd Aslam , Agrawal Vivek

Background: AdipoQ gene is located at the 3rd chromosome and encodes foradiponectin which is involved in fat metabolism and insulin sensitivity and plays a protective role in diabetes and atherogenesis. AdipoQgene variants have been reported to be associated with hypertriglyceridemia and risk of diabetes in different studies. We aimed to study whether polymorphism of rs2241766 polymorphic form of AdipoQ gene & its expression in adipose tissue is associated with post prandi...

ea0031p375 | Thyroid | SFEBES2013

Evaluation of fine needle aspiration and ultrasound in diagnostic assessment of thyroid nodules

Sagi SV , Berman L , Chatterjee VKK , Simpson HL

Objective: To evaluate the outcome of fine needle aspiration biopsy (FNAB) of solid thyroid nodules, and the utility of thyroid ultrasound in determining the nature of solid nodules in our practice.Methods: We reviewed the diagnostic outcome of FNAB of solid thyroid nodules in 93 patients from our dedicated thyroid biopsy clinic. In addition we compared the predictive value of sonographic assessment with FNAB in a subset of patients who had undergone bot...

ea0019p36 | Clinical practice/governance and case reports | SFEBES2009

Carbimazole-induced myositis: a rare but significant adverse reaction

Sagi SV , Sayeed N , Oyibo SO , Roland JM

Introduction: Carbimazole is the first drug of choice for treating thyrotoxicosis. We report a case of an Asian gentleman recently started on carbimazole for thyrotoxicosis who complained of severe generalised muscle pain and weakness.Report: A sixty-four year old gentleman was diagnosed with thyrotoxicosis (TSH <0.01 mU/l, Free T4=40 pmol/l, Free T3=14.9 pmol/l) in the month of July 08 and was started on carbimazole 40 mg daily...

ea0011p73 | Clinical case reports | ECE2006

Familial hyperparathyroidism with a mutation in the HRPT2 gene

Goulden P , Bano G , Ajith Kumar VK , Hodgson SV , Nussey SS

A 72 years old lady was referred to endocrine clinic with raised serum calcium of 2.69 mmol/l and PTH of 99.6 ng/l (3.0–48.0 ng/l) detected during investigations for an abnormal skeletal survey. She was known to have osteoporosis from the age of 59 diagnosed on Dexa scan. Case notes revealed raised serum calcium of 2.52–2.60 mmol/l since year 2000. Her repeat serum calcium was 2.77 mmol/l with phosphate of 1.03 mmol/l and 25 hydroxy vitamin D of 36 nmol/l. She admitt...

ea0011p74 | Clinical case reports | ECE2006

Pendred’s syndrome with three mutations

Goulden P , Bano G , Ajith Kumar VK , Hodgson SV , Nussey SS

This 48-year-old with consanguineous parentage presented at the age of 23 in 1980 with congenital bilateral sensorineural deafness and hypothyroidism requiring replacement with 150 mcg thyroxine. There was a family history of deafness and thyroid disease. A perchlorate discharge test was performed and 42% of the radioiodine within the gland was discharged by potassium perchlorate (NR <10%).Over the following decade she developed a diffuse goitre whic...

ea0011p736 | Steroids | ECE2006

The New Zealand White Albino Rabbit is a suitable model for the evaluation of 11β-hydroxysteroid dehydrogenase type 1 activity in ocular tissues

Onyimba CU , Khosla P , Hughes SV , Murray PI , Stewart PM , Walker EA , Rauz S

Ion and fluid transport mechanisms within the eye are important for several key physiological processes including the maintenance of corneal transparency and the regulation of intraocular pressure (IOP). The mechanism involved in epithelial sodium transport in the eye is regulated by corticosteroids and at a pre-receptor level, by 11β-hydroxysteroid dehydrogenase (11β-HSD) activity. Recent studies localised type 1 (11β-HSD1), an oxo-reductase that activates cort...

ea0090p348 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Bexagliflozin in Patients with Type 2 Diabetes: Scoping Review of the Published Randomised Control Trials

Redkar Vivek , Redkar Sagar , Redkar Supriya , Manohar Manohar , Inamdar Aniket , Jumani Deepak , Kulkarni SV , Das Shreya , Das Rajarshee , Arora Muskan

Introduction: US Food and Drug Administration (FDA) has recently approved bexagliflozin, a new SGLT2 inhibitor. We examined the outcomes and metabolic effects of Bexagliflozin across the published Randomised Controlled Trials (RCCTs)Methods: A comprehensive literature search was done to extract publications from Medline-PubMed and Cochrane library, since inception till January 20, 2023, then screened and reviewed by two independent reviewers. Data includ...

ea0070aep680 | Pituitary and Neuroendocrinology | ECE2020

fMRI for cognitive evaluation of adult survivors of childhood craniopharyngioma

Svärd Daniel , Marie Erfurth Eva , Fjalldal Sigridur , Hellerstedt Robin , Mannfolk Peter , Mårtensson Johan , Follin Cecilia

Introduction: The morbidity of craniopharyngioma (CP) includes cognitive dysfunction with attention deficits, impaired episodic memory and processing speed (Fjalldal et al., 2013) and CP patients with hypothalamic damage are more affected. fMRI is a technique used to investigate cortical activity by detecting alterations in blood flow in response to stimuli or actions. Previously pre- and post-meal fMRI responses to visual food cues were investigated showing higher ac...